Neuroone Medical Technologies Corp (NMTC)

$4.76 +0.01 (0.21%)
Market Cap 40.01M
Revenue (ttm) 12.10M
Net Income (ttm) -3.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.83%
Debt to Equity Ratio 0.00
Volume 16,300
Avg Vol 42,073
Day's Range N/A - N/A
Shares Out 8.42M
Stochastic %K 63%
Beta 0.63
Analysts Strong Sell
Price Target $12.20

Company Profile

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 426 1383
Website: nmtc1.com
Address:
7599 Anagram Drive, Eden Prairie, United States
JohnStuartMill
JohnStuartMill Apr. 24 at 6:02 PM
$NMTC Example posted 4/7: "@GiftedAutismTM That was a very accurate assessment of all 4 stocks. As my investments are somewhat play money looking for home runs as opposed to singles, I'm in $AAOI and $POET. " SINCE 4/7 $POET UP 150% $AAOI UP 50% Also since 4/7 $CRDO UP 90% $SNDK UP 40% Can add several others and the Leap call options are up 2 to 3 times the share price performance.
1 · Reply
JohnStuartMill
JohnStuartMill Apr. 24 at 5:42 PM
$NMTC Although it is very entertaining watching those who look at numbers and charts and graphs, who have no concept of the myriad intricacies of HFT, who then either grasp at straws for much needed validation or create self delusional scenarios to try to explain what they are unable to comprehend. But, it's OK, we understand, much easier mentally to just blame MM's or algos or shorters or the boogeyman.
1 · Reply
JohnStuartMill
JohnStuartMill Apr. 24 at 5:24 PM
$NMTC Accurate objective assessment of risk reward ratios is one traits which separates the bourgeoisie from the proletariat.
1 · Reply
macroaxis
macroaxis Apr. 24 at 2:14 PM
$NMTC — Pin risk eases as more NeuroOne Medical options traders enter the market https://www.macroaxis.com/stock-options/NMTC/Neuroone-Medical-Technologies?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
IncognitoBull
IncognitoBull Apr. 24 at 12:29 PM
$NMTC games. Is that you John? Gotta be right = narcissism
0 · Reply
IncognitoBull
IncognitoBull Apr. 24 at 11:46 AM
$NMTC
0 · Reply
JohnStuartMill
JohnStuartMill Apr. 24 at 6:35 AM
$NMTC WAIT FOR IT
0 · Reply
JohnStuartMill
JohnStuartMill Apr. 24 at 6:34 AM
$NMTC TICK TICK TICK
0 · Reply
Reminderz
Reminderz Apr. 23 at 8:06 PM
$HUBC $EHGO $PMAX $NMTC thing
0 · Reply
IncognitoBull
IncognitoBull Apr. 23 at 5:16 PM
$NMTC need some updates on the pain front. Mayo....NMTC partner and shareholder
0 · Reply
Latest News on NMTC
NeuroOne Medical Technologies Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 17, 2026, 1:20 PM EDT - 5 weeks ago

NeuroOne Medical Technologies Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

NeuroOne Medical Technologies Transcript: Investor update

Mar 12, 2026, 11:30 AM EDT - 6 weeks ago

NeuroOne Medical Technologies Transcript: Investor update

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2026

Feb 17, 2026, 8:30 AM EST - 2 months ago

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2026

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2025

Dec 17, 2025, 8:30 AM EST - 4 months ago

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2025

NeuroOne Medical Technologies Transcript: Investor Update

Oct 7, 2025, 8:30 AM EDT - 7 months ago

NeuroOne Medical Technologies Transcript: Investor Update

NeuroOne Medical Technologies Transcript: Small-Cap Virtual Conference

Sep 17, 2025, 12:15 PM EDT - 7 months ago

NeuroOne Medical Technologies Transcript: Small-Cap Virtual Conference

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

Sep 8, 2025, 4:05 PM EDT - 8 months ago

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Aug 18, 2025, 8:30 AM EDT - 8 months ago

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne Medical Technologies Earnings Call Transcript: Q3 2025

Aug 14, 2025, 8:30 AM EDT - 9 months ago

NeuroOne Medical Technologies Earnings Call Transcript: Q3 2025

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

Aug 14, 2025, 7:30 AM EDT - 9 months ago

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

Jul 31, 2025, 12:12 PM EDT - 9 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

Jul 31, 2025, 8:30 AM EDT - 9 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Jul 23, 2025, 8:30 AM EDT - 9 months ago

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

Jun 23, 2025, 8:30 AM EDT - 10 months ago

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

Jun 3, 2025, 8:30 AM EDT - 11 months ago

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

May 29, 2025, 1:05 PM EDT - 11 months ago

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2025

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

May 13, 2025, 7:30 AM EDT - 1 year ago

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

May 12, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

May 5, 2025, 4:01 PM EDT - 1 year ago

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

May 1, 2025, 9:55 AM EDT - 1 year ago

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Apr 23, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® Issues Letter to Shareholders

Apr 16, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® Issues Letter to Shareholders

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Apr 14, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

Apr 4, 2025, 12:57 PM EDT - 1 year ago

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

Apr 4, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

Apr 3, 2025, 4:05 PM EDT - 1 year ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

Mar 18, 2025, 1:12 PM EDT - 1 year ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

Mar 18, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

Mar 18, 2025, 8:46 AM EDT - 1 year ago

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Mar 11, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Mar 5, 2025, 9:00 AM EST - 1 year ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2025

Feb 12, 2025, 8:30 AM EST - 1 year ago

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2025

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

Feb 12, 2025, 8:00 AM EST - 1 year ago

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

Feb 5, 2025, 11:00 AM EST - 1 year ago

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

Feb 4, 2025, 10:56 AM EST - 1 year ago

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

NeuroOne Medical Technologies Transcript: Status Update

Jan 10, 2025, 11:00 AM EST - 1 year ago

NeuroOne Medical Technologies Transcript: Status Update

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

Jan 10, 2025, 8:30 AM EST - 1 year ago

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

Jan 3, 2025, 8:30 AM EST - 1 year ago

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2024

Dec 17, 2024, 9:00 AM EST - 1 year ago

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2024

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

Dec 17, 2024, 8:30 AM EST - 1 year ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

Nov 13, 2024, 9:30 AM EST - 1 year ago

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

Oct 31, 2024, 4:01 PM EDT - 1 year ago

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

Sep 24, 2024, 9:30 AM EDT - 1 year ago

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

Sep 10, 2024, 9:00 AM EDT - 1 year ago

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 5, 2024, 6:23 PM EDT - 1 year ago

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NeuroOne Medical Technologies Earnings Call Transcript: Q3 2024

Aug 14, 2024, 4:30 PM EDT - 1 year ago

NeuroOne Medical Technologies Earnings Call Transcript: Q3 2024

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 4:00 PM EDT - 1 year ago

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

Aug 12, 2024, 11:30 AM EDT - 1 year ago

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

Jun 20, 2024, 9:30 AM EDT - 2 years ago

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2024

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

May 14, 2024, 4:00 PM EDT - 2 years ago

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

May 10, 2024, 2:43 PM EDT - 2 years ago

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

Apr 10, 2024, 9:00 AM EDT - 2 years ago

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

Apr 9, 2024, 9:05 AM EDT - 2 years ago

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.

Apr 4, 2024, 9:00 AM EDT - 2 years ago

NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

Mar 26, 2024, 9:00 AM EDT - 2 years ago

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

NeuroOne® to Participate in the 36th Annual Roth Conference

Mar 8, 2024, 12:00 PM EST - 2 years ago

NeuroOne® to Participate in the 36th Annual Roth Conference

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 23, 2024, 5:10 PM EST - 2 years ago

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2024

Feb 13, 2024, 4:30 PM EST - 2 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2024

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Feb 13, 2024, 4:00 PM EST - 2 years ago

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

Feb 8, 2024, 3:30 PM EST - 2 years ago

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2023

Dec 14, 2023, 5:00 PM EST - 2 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2023

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

Dec 14, 2023, 4:15 PM EST - 2 years ago

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

Dec 7, 2023, 4:30 PM EST - 2 years ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

NeuroOne Medical Technologies Earnings Call Transcript: Q3 2023

Aug 14, 2023, 4:30 PM EDT - 2 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q3 2023

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2023

May 11, 2023, 4:00 PM EDT - 3 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2023

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2023

Feb 14, 2023, 4:30 PM EST - 3 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2023

JohnStuartMill
JohnStuartMill Apr. 24 at 6:02 PM
$NMTC Example posted 4/7: "@GiftedAutismTM That was a very accurate assessment of all 4 stocks. As my investments are somewhat play money looking for home runs as opposed to singles, I'm in $AAOI and $POET. " SINCE 4/7 $POET UP 150% $AAOI UP 50% Also since 4/7 $CRDO UP 90% $SNDK UP 40% Can add several others and the Leap call options are up 2 to 3 times the share price performance.
1 · Reply
JohnStuartMill
JohnStuartMill Apr. 24 at 5:42 PM
$NMTC Although it is very entertaining watching those who look at numbers and charts and graphs, who have no concept of the myriad intricacies of HFT, who then either grasp at straws for much needed validation or create self delusional scenarios to try to explain what they are unable to comprehend. But, it's OK, we understand, much easier mentally to just blame MM's or algos or shorters or the boogeyman.
1 · Reply
JohnStuartMill
JohnStuartMill Apr. 24 at 5:24 PM
$NMTC Accurate objective assessment of risk reward ratios is one traits which separates the bourgeoisie from the proletariat.
1 · Reply
macroaxis
macroaxis Apr. 24 at 2:14 PM
$NMTC — Pin risk eases as more NeuroOne Medical options traders enter the market https://www.macroaxis.com/stock-options/NMTC/Neuroone-Medical-Technologies?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
IncognitoBull
IncognitoBull Apr. 24 at 12:29 PM
$NMTC games. Is that you John? Gotta be right = narcissism
0 · Reply
IncognitoBull
IncognitoBull Apr. 24 at 11:46 AM
$NMTC
0 · Reply
JohnStuartMill
JohnStuartMill Apr. 24 at 6:35 AM
$NMTC WAIT FOR IT
0 · Reply
JohnStuartMill
JohnStuartMill Apr. 24 at 6:34 AM
$NMTC TICK TICK TICK
0 · Reply
Reminderz
Reminderz Apr. 23 at 8:06 PM
$HUBC $EHGO $PMAX $NMTC thing
0 · Reply
IncognitoBull
IncognitoBull Apr. 23 at 5:16 PM
$NMTC need some updates on the pain front. Mayo....NMTC partner and shareholder
0 · Reply
IncognitoBull
IncognitoBull Apr. 23 at 10:55 AM
$NMTC
0 · Reply
IncognitoBull
IncognitoBull Apr. 23 at 10:39 AM
$NMTC dude never gets laid.....
1 · Reply
JohnStuartMill
JohnStuartMill Apr. 23 at 8:36 AM
$NMTC MORE INFO: More Brain Pratt SPAC results. His Arpeggio Acquisition Corp merged with Hill International, SPAC shares sold for $10, merged IPO opened at $5.30, sold to private company for $3.40. Investors LOST, but management made a fortune. Trio Merger Corp merged with SAExploration Holdings (SAEX), merged IPO opened at $10.15, went Down to 30 CENTS and declared Bankruptcy. DEAL after DEAL after DEAL, investors LOST BIG MONEY, but SPAC management MADE a fortune. YES, GREAT track record to believe in.
0 · Reply
JohnStuartMill
JohnStuartMill Apr. 23 at 7:58 AM
$NMTC Is there a difference between hopium blind belief and actual due diligence? Yes, the former lets one cling to any tidbit as a means of continuing in their hopium blind belief stupor state, and the latter provides facts, knowledge and data so one can make an unbiased, objective and well informed decision.
0 · Reply
JohnStuartMill
JohnStuartMill Apr. 23 at 7:28 AM
$NMTC Gee, I wonder what Legato IV is set up to do? Here is an important question: did Brian Pratt own any part of Algoma or Southland BEFORE the SPAC mergers? Here is another important question: Is there a difference between hopium blind belief and actual due diligence?
0 · Reply
JohnStuartMill
JohnStuartMill Apr. 23 at 7:27 AM
$NMTC Brian Pratt and Legato Merger Corp (a SPAC company), SPAC = Special Purpose Acquisition Company. Legato I merged with Algoma Steel Group (ASTL), DOWN 52% since merge. BUT the SPAC owners made a fortune. Legato II merged with Southland Holdings (SLND), DOWN 87% since merge. BUT the SPAC owners made a fortune. Legato III set to merge with Einride (Electric/Autonomous Trucking) (will trade as ENRD), currently Losing about 100 Million per year. BUT the SPAC owners will make a fortune. Gee, I wonder what Legato IV is set up to do?
0 · Reply
JohnStuartMill
JohnStuartMill Apr. 23 at 6:44 AM
$NMTC FACTUAL Net Worth for Brian Pratt. HINT: Not 25 Million. As of April 2026, Brian Pratt has an estimated net worth of at least $672 million to $1.17 billion, driven by his holdings in Primoris Services Corp, Limbach Holdings, and Energy Services of America Corp. He is a significant insider with millions of shares in these infrastructure and construction firms, with his Primoris Services Corp stock alone valued at over $450 million. Net Worth Breakdown: Estimated at $1.17 billion (Benzinga) or over $672 million (GuruFocus) as of April 2026.
0 · Reply
IncognitoBull
IncognitoBull Apr. 22 at 6:49 PM
$NMTC no one buys 627k shares of a low float stoxk with intent to sell any time soon. Our volume doesn't support flipping large share counts. That is a full bull move. Over $2.7M in dollars if you use the $4.44 split price
0 · Reply
IncognitoBull
IncognitoBull Apr. 22 at 3:08 PM
$NMTC
0 · Reply
IncognitoBull
IncognitoBull Apr. 22 at 2:49 PM
$NMTC https://www.linkedin.com/safety/go/?url=https%3A%2F%2Flnkd%2Ein%2FgZPtcvf4&urlhash=HQ0i&mt=ls1vZ3ODMR0CqMe4a30QB-uaZO8H_5gHCHU3fKAns19uNPvGiK1Hej79CzOQZLTQ9bDACwL3OzoAgy9su8Ou2JzByjCD_8LRMs0X-rzRMYR-WqLhOzk3GETTmw&isSdui=true
0 · Reply
IncognitoBull
IncognitoBull Apr. 22 at 2:43 PM
$NMTC Brian Pratt, net worth of $25M has 7.4% ownership in NMTC with 627k shares m/l. (SEC filing yesterday)
0 · Reply
IncognitoBull
IncognitoBull Apr. 21 at 7:07 PM
$NMTC when I say games.....it is a low volume stock. Algos hunt for stop losses and limit sales....sell 1 share at a low price to drop price and it triggers stop losses....they get your shares cheap. Sell 1 share at a high price to bring it up and they get your shares when your sale hits. Games.
0 · Reply